Speciality: Oncology
Description:
Welcome to this insightful overview on the incidence of lung cancer, with a special focus on ALK-rearranged NSCLC, presented by the esteemed Dr. Vamshi Krishna M. In this video, Dr. Vamshi provides a comprehensive understanding of the prevalence, risk factors, and key statistics associated with lung cancer, while delving deeper into the unique characteristics of ALK-rearranged non-small cell lung cancer (NSCLC). His expertise sheds light on why this specific genetic alteration is critical in diagnosis and treatment, offering valuable insights for medical professionals and researchers alike.
Dr. Vamshi Krishna M further explores the diagnostic challenges and advancements in detecting ALK rearrangements, emphasizing the importance of targeted therapies in improving patient outcomes. He discusses the latest research, treatment protocols, and the evolving landscape of precision medicine in managing ALK-positive NSCLC. This discussion serves as an essential resource for oncologists, pulmonologists, and healthcare practitioners seeking to enhance their knowledge in this specialized area of lung cancer care.
We hope this video provides you with a deeper understanding of ALK-rearranged NSCLC and its significance in modern oncology. Stay tuned for more expert-led discussions and updates on cutting-edge advancements in cancer research and treatment. Don’t forget to watch till the end and subscribe for future informative sessions!
See More Webinars @ Hidoc Webinars
1.
AI-based breast cancer risk technology receives FDA breakthrough device designation
2.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
3.
examining differences in the rates of breast reconstruction following mastectomies.
4.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
5.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
1.
Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts
2.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
3.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
4.
Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment
5.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation